FI903197A0 - Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi - Google Patents

Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi

Info

Publication number
FI903197A0
FI903197A0 FI903197A FI903197A FI903197A0 FI 903197 A0 FI903197 A0 FI 903197A0 FI 903197 A FI903197 A FI 903197A FI 903197 A FI903197 A FI 903197A FI 903197 A0 FI903197 A0 FI 903197A0
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical preparation
proteinaceous pharmaceutical
preparation
protein
Prior art date
Application number
FI903197A
Other languages
English (en)
Swedish (sv)
Other versions
FI94927B (fi
FI94927C (fi
Inventor
Hans Peter Schwarz
Ewald Molinari
Yendra Linnau
Susanne Pfeiler
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI903197A0 publication Critical patent/FI903197A0/fi
Publication of FI94927B publication Critical patent/FI94927B/fi
Application granted granted Critical
Publication of FI94927C publication Critical patent/FI94927C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI903197A 1989-06-26 1990-06-26 Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi FI94927C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT155189 1989-06-26
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation

Publications (3)

Publication Number Publication Date
FI903197A0 true FI903197A0 (fi) 1990-06-26
FI94927B FI94927B (fi) 1995-08-15
FI94927C FI94927C (fi) 1995-11-27

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903197A FI94927C (fi) 1989-06-26 1990-06-26 Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi

Country Status (10)

Country Link
US (1) US5143901A (fi)
EP (1) EP0406216B1 (fi)
JP (1) JPH0338528A (fi)
AT (2) AT402153B (fi)
CA (1) CA2019745C (fi)
DE (1) DE59003060D1 (fi)
DK (1) DK0406216T3 (fi)
ES (1) ES2061007T3 (fi)
FI (1) FI94927C (fi)
NO (1) NO902823L (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
CA2143125C (en) * 1992-08-27 2008-09-23 Koenraad Mertens Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
WO2001056532A2 (en) * 2000-02-04 2001-08-09 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
US20230265211A1 (en) * 2020-06-29 2023-08-24 Inserm (Institut National De La Santé Et De Ls Recherche Médicale) Anti-protein s single-domain antibodies and polypeptides comprising thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
US5143901A (en) 1992-09-01
EP0406216A2 (de) 1991-01-02
NO902823D0 (no) 1990-06-25
NO902823L (no) 1990-12-27
FI94927B (fi) 1995-08-15
FI94927C (fi) 1995-11-27
CA2019745C (en) 1996-12-31
ES2061007T3 (es) 1994-12-01
EP0406216A3 (en) 1991-02-06
JPH0338528A (ja) 1991-02-19
ATA155189A (de) 1996-07-15
AT402153B (de) 1997-02-25
DK0406216T3 (da) 1994-01-17
EP0406216B1 (de) 1993-10-13
ATE95818T1 (de) 1993-10-15
CA2019745A1 (en) 1990-12-26
DE59003060D1 (de) 1993-11-18

Similar Documents

Publication Publication Date Title
DE3889536T2 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
GR3004582T3 (fi)
DE68924623D1 (de) Polytetrafluorethylenfilament und Verfahren zur Herstellung derselben.
DE69228073D1 (de) Prozess zur darstellung von (5r)-1,1-dimethylethyl-6-cyano-5-oxo-hexanoaten
DE68908616D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluor-2,2-dichlorethan.
CA2001572A1 (en) Compositions for treating tobacco withdrawal symptoms
DE59002438D1 (de) L-Carnitin-Magnesium-Zitrat.
FI903197A0 (fi) Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
DE69004501T2 (de) Materialbehandlungsverfahren.
AU561222B2 (en) Process for the pasteurization of human plasma
DE68905327T2 (de) Verfahren zur Herstellung von 1,1,1,2-tetrafluorethan.
HUT59136A (en) Process for producing 3-(pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
ATE96280T1 (de) Verfahren zur herstellung eines pflanzlichen eiweisshydrolysats und so hergestelltes produkt.
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
ATE52894T1 (de) Schwarztrueffelaroma.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
IT1239273B (it) Procedimento di preparazione di aromi naturali al tartufo e prodotti ottenuti.
DE69008488T2 (de) Verfahren zur Herstellung von N-Alkylaminophenolen und von N,N-Dialkylaminophenolen.
BG50904A1 (en) A process for different species origin cholinesterase preparation
DE59003723D1 (de) Verfahren zur Herstellung virusfreier Naturstoffe.
DE68910806D1 (de) Verfahren zur Herstellung von 4,4'''-Dihydroxyquaterphenyl oder deren Derivaten.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT